Mammography Screening Guidelines
All women should begin annual screening mammography at age 40 and continue through age 74, with continuation beyond age 75 based on life expectancy greater than 7 years and overall good health. 1
Standard Risk Women
Starting Age and Interval
- Begin annual mammography at age 40 (no later than 40) 1
- Annual screening provides 37% median mortality reduction when performed from ages 40-75, superior to biennial screening 1
- Mortality reduction is significantly greater when screening begins at 40 versus 45 or 50 years of age 1
Screening After Age 75
- No upper age limit exists for mammography screening 1
- Continue screening if:
- Base decisions on life expectancy and comorbidities rather than age alone, as mortality reduction requires years to be fully attained 1
Modality
- Digital breast tomosynthesis (DBT) is preferred over standard digital mammography when available 1, 2
- DBT increases cancer detection rate by 1.6-3.2 per 1,000 examinations and decreases recall rate by 2.2% compared to digital mammography 1
High-Risk Women
Genetic/Familial Risk
Start annual mammography at age 30 OR 10 years before youngest affected family member, whichever is later (generally not before age 30) 1
- BRCA mutation carriers can delay mammography until age 40 if annual breast MRI is performed starting at age 25-30 3
- One-third of breast cancers in BRCA2 carriers <40 years are only detected on mammography 1
- For ages 50-69, combining MRI and mammography significantly increases sensitivity (96.3% vs 90.9% for MRI alone) 1
Personal History of Breast Cancer
- Annual mammography for surveillance following breast conservation therapy 1
- If diagnosed before age 50 OR with dense breasts: add annual supplemental breast MRI 3
Prior Benign High-Risk Lesions
For lobular neoplasia, atypical lobular hyperplasia, classic lobular carcinoma in situ, or atypical ductal hyperplasia:
- If diagnosed before age 40: begin annual mammography at time of diagnosis (generally not before age 30) 1
- If diagnosed after age 40: strongly consider annual supplemental breast MRI, especially with other risk factors 3
Calculated Lifetime Risk ≥20%
- Annual breast MRI starting at ages 25-30 3
- Annual mammography with variable starting age between 25-40 depending on risk type 3
Prior Chest Radiation (before age 30)
Dense Breasts
Dense breast tissue (BI-RADS C or D) is an independent risk factor with relative risks of 1.2 for heterogeneously dense and 2.1 for extremely dense breasts 1
Supplemental Screening Options (in order of preference):
- Breast MRI - recommended first-line supplemental screening for women desiring additional imaging 3
- Contrast-enhanced mammography - if MRI contraindicated or unavailable 3
- Ultrasound - if MRI contraindicated or unavailable 3
- Digital breast tomosynthesis - consider based on benefits, harms, radiation exposure, availability, and cost 4
Do NOT use supplemental MRI or ultrasound routinely in average-risk women with dense breasts per some guidelines 4, though ACR recommends MRI for those desiring supplemental screening 3
Screening During Pregnancy and Lactation
Pregnancy (Age ≥40)
- Continue annual mammography screening - it is safe during pregnancy 5
- Scatter radiation to fetus is negligible 5
- Tomosynthesis with mammography is preferred and may provide added benefit in denser breast tissue of pregnancy 5
- Contrast-enhanced mammography is NOT recommended - iodinated contrast crosses placenta with unknown fetal effects 5
- MRI with gadolinium is CONTRAINDICATED - gadolinium crosses placenta and may dissociate into toxic free gadolinium ions in amniotic fluid 5
- Biopsies can be performed as needed (discuss milk fistula and bleeding risks) 5
Lactation
- Refer to ACR Appropriateness Criteria on "Breast Imaging of Pregnant and Lactating Females" for specific guidance 1
Special Populations
Ashkenazi Jewish and African American Women
- Perform risk assessment by age 25 - these populations have increased risk for BRCA and other mutations 3
- Black women have disproportionately higher mortality rates despite not having highest incidence 1
Common Pitfalls
- Do not delay screening to age 50 - mortality reduction is significantly greater starting at 40 1
- Do not stop screening at arbitrary age cutoffs - use life expectancy and health status instead 1
- Do not skip mammography in high-risk women receiving MRI - mammography still detects cancers missed by MRI alone, especially in women ≥50 1
- Do not use biennial screening when annual is feasible - annual screening provides superior mortality reduction 1